TRT Trio-Tech International Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
19:22
Sep 03
Sep 03
Portfolio reweighting shows reduced positions in existing holdings, new small stakes added.
Portfolio reweighting shows reduced positions in existing holdings, new small stakes added, and complete exits from ten tickers, reflecting a strategic shift toward cash and selective reallocation.
19:23
Aug 28
Aug 28
Holding TRT position despite being red
Author discloses an existing TRT position currently at a loss but not exited, indicating continued holding despite being underwater. No explicit catalyst or target given; position-disclosure only.
MED
19:19
Aug 28
Aug 28
Sarcastic jab at losing money on TRT
Sarcastic commentary critical of paying for a Substack subscription that has lost money on TRT; no personal directional commitment or position disclosed.
LOW
10:59
Aug 28
Aug 28
The author explicitly states they no longer track TRT and cannot provide an opinion.
The author explicitly states they no longer track TRT and cannot provide an opinion, so the ticker is only indexed as a mention without any directional view.
LOW
13:05
Aug 27
Aug 27
Author holds NVDA as over 40% of an all-in portfolio and lists AI beneficiaries as watchlist.
Author holds NVDA as over 40% of an all-in portfolio and lists AI beneficiaries as watchlist names, not owned positions, while framing NVDA earnings as confirming the AI trade's strength.
LOW
13:04
Aug 27
Aug 27
AI beneficiaries positioned for five-year growth
Author identifies AI beneficiaries from NVDA earnings strength, implying continued demand for AI infrastructure over multi-year horizon.
MED
02:14
Aug 27
Aug 27
TRT flagged as AI testing beneficiary after Nvidia earnings.
Author lists TRT as a testing beneficiary of NVDA earnings, but explicitly states it is an idea generation list, not a buy signal, yielding a cautious long watch.
MED
12:43
Aug 17
Aug 17
Most bullish on TRT, AEHR-like micro-cap
Buy TRT: author is most bullish in this setup; the setup includes an under-the-radar, extremely small market cap and similarities to AEHR, a company with 40x larger market cap.
MED
14:31
Aug 13
Aug 13
Author monitors stock ahead of upcoming earnings
Author is closely monitoring the stock ahead of earnings, referencing a quoted thesis about upcoming backlog disclosures and AI orders.
MED
11:37
Aug 13
Aug 13
TRT: business misaligned, single-customer risk
Watch TRT rather than chase it; the author sees a business model misaligned with market needs, boards that can be designed out, and heavy single-customer concentration—risky for a small company. No author position.
MED
21:48
Aug 10
Aug 10
Author sold a position to rotate into NBIS for better risk/reward.
Author sold a position to rotate into NBIS for better risk/reward, while calling TRT not bad but not a strong conviction.
LOW
03:13
Jul 19
Jul 19
The author lists a broad basket of stocks to accumulate during a sell-off and explicitly calls.
The author lists a broad basket of stocks to accumulate during a sell-off and explicitly calls out personal favorites as high-conviction holdings, framing
LOW
13:39
Jul 15
Jul 15
Author highlights a 50% move in AEHR and calls it insane while referencing a prior bullish call.
Author highlights a 50% move in AEHR and calls it insane while referencing a prior bullish call breakdown and add in the low 70's, indicating a long position.
LOW
01:18
Jul 15
Jul 15
Speculates that Q2 earnings could be a positive catalyst for TRT and INTT.
Speculates that Q2 earnings could be a positive catalyst for TRT and INTT, but no personal directional commitment; rhetorical question per speaker note defaults to WATCH.
LOW
21:50
Jul 14
Jul 14
Author expresses surprise at TRT's 20% move in sympathy with AEHR but does not state a personal.
Author expresses surprise at TRT's 20% move in sympathy with AEHR but does not state a personal position or forward catalyst.
LOW
21:41
Jul 14
Jul 14
Monitor TRT as a listed name in the GAI test tracker; research basket.
Monitor TRT as a listed name in the GAI test tracker; research basket, not an active author pick.
MED
20:11
Jul 14
Jul 14
Author is long AEHR ahead of earnings with high conviction from prior context and sees TRT.
Author is long AEHR ahead of earnings with high conviction from prior context and sees TRT as a sympathy play worth watching.
LOW
03:34
Jul 02
Jul 02
The author notes strength in test equipment companies but questions why TRT is not.
The author notes strength in test equipment companies but questions why TRT is not participating, without taking a directional position.
LOW
01:08
Jul 02
Jul 02
Author likes MRLN and IQE as nice adds and considers TRT good to consider.
Author likes MRLN and IQE as nice adds and considers TRT good to consider, endorsing the parent's added positions as bullish candidates.
LOW
09:12
Jun 30
Jun 30
Author shares a portfolio allocation breakdown with percentages but provides no forward-looking.
Author shares a portfolio allocation breakdown with percentages but provides no forward-looking trade thesis or position change, making this a factual update rather than a directional call.
LOW
09:16
Jun 27
Jun 27
Author notes Mirae looks good but will never trade close to Techwing due to its lower-value.
Author notes Mirae looks good but will never trade close to Techwing due to its lower-value supply chain position, while still expecting it to do well.
LOW
03:18
Jun 27
Jun 27
Author trimmed TRT position during the week as part of rotation into BB; partial exit disclosed.
MED
16:04
Jun 26
Jun 26
Author discloses ongoing 4% TRT position, unchanged through portfolio rebalance.
Author discloses ongoing 4% TRT position, unchanged through portfolio rebalance — small but retained allocation.
MED
08:54
Jun 26
Jun 26
Author discloses TRT as a current portfolio holding.
Author discloses TRT as a current portfolio holding; no specific catalyst provided beyond active ownership.
MED
07:50
Jun 25
Jun 25
The author asks a clarifying question about ownership of TRT without expressing any personal.
The author asks a clarifying question about ownership of TRT without expressing any personal directional view or position.
LOW
20:10
Jun 24
Jun 24
Author discloses TRT as a current portfolio holding at 4% weight in an explicit portfolio.
Author discloses TRT as a current portfolio holding at 4% weight in an explicit portfolio update.
MED
18:06
Jun 24
Jun 24
The author gives a general bullish pep talk to buy stocks on red days but lists tickers.
The author gives a general bullish pep talk to buy stocks on red days but lists tickers as personal favorites without explicit position language or forward price targets.
LOW
04:29
Jun 21
Jun 21
Speaker expresses minimal interest in $TRT without directional view, catalyst, or commitment.
LOW
03:32
Jun 21
Jun 21
Author initiated a new position in TRT, a semiconductor test and burn-in services company.
Author initiated a new position in TRT, a semiconductor test and burn-in services company; sector thesis tied to semiconductor equipment/services cycle.
MED
22:51
Jun 19
Jun 19
Author discloses a current long position in $TRT with no stated catalyst or reasoning beyond.
Author discloses a current long position in $TRT with no stated catalyst or reasoning beyond the position itself.
MED
About TRT Analyst Coverage
Buzzberg tracks TRT (Trio-Tech International) across 20 sources. 37 bullish vs 0 bearish calls from 19 analysts. Sentiment: predominantly bullish (34%). 109 total trade ideas tracked. Past 7 days: 1 watch. Latest voices: ren_stocks, italianinvesto, ParadisLabs.